文献速递前列腺癌

局限期前列腺癌根治性前列腺切除术后不良分期迁移的趋势

Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer.
PubMed 文献 · Eur Urol Oncol · 2018-05-15

基于美国监测、流行病学和最终结果数据库(2010-2014年)纳入58 558例临床局限期(T1-2、活检Gleason分级分组1-3)接受根治性前列腺切除术的前列腺癌患者,分析非器官局限(NOC)和病理原发性Gleason≥4比例的年变化趋势。结果显示NOC比例从18.7%升至24.2%(p=0.002),校正后从16.9%升至22.3%(p=0.001);病理原发性Gleason≥4比例从16.8%升至23.0%(p=0.001),校正后从10.8%升至14.2%(p=0.002)。

要点

  • NOC前列腺癌比例从18.7%升至24.2%(p=0.002),校正后从16.9%升至22.3%(p=0.001)。
  • 病理原发性Gleason≥4比例从16.8%升至23.0%(p=0.001),校正后从10.8%升至14.2%(p=0.002)。
  • 作者认为该趋势可能与北美患者对主动监测和观察等待的接受度提高有关。

核心结论

  • 在当代北美接受根治性前列腺切除术的患者中,非器官局限前列腺癌和病理原发性Gleason≥4前列腺癌的比例随时间增加。
  • 作者认为这一发现可能与北美患者对主动监测和观察等待的接受度提高有关。

研究设计与样本

  • 基于监测、流行病学和最终结果数据库(2010-2014年)的回顾性队列分析,纳入58 558例临床T1-2、活检Gleason分级分组1-3且接受根治性前列腺切除术的局限期前列腺癌患者。
  • 采用年度趋势分析和多变量逻辑回归模型,校正临床肿瘤特征(前列腺特异性抗原、临床分期、活检Gleason分级分组)。

主要发现

  • 非器官局限前列腺癌比例从18.7%升至24.2%(p=0.002),校正后从16.9%升至22.3%(p=0.001)。
  • 病理原发性Gleason≥4前列腺癌比例从16.8%升至23.0%(p=0.001),校正后从10.8%升至14.2%(p=0.002)。
  • 两个终点联合分析时记录到几乎相同的发现。
  • 将诊断年份作为连续变量、分类变量或采用三次样条方法的多变量逻辑回归分析均证实了上述结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two recent European studies showed an increasing proportion of non-organ-confined (NOC; pathologic stages T3-4) prostate cancer (PCa) in radical prostatectomy (RP) specimens. OBJECTIVE: To determine if the trend for NOC and pT3-4 PCa is also evident among contemporary North American patients. DESIGN, SETTING, AND PARTICIPANTS: Within the Surveillance, Epidemiology, and End Results database (2010-2014), we identified 58 558 patients with clinically localized PCa treated with RP. Only patients with clinical stage T1-2 and biopsy Gleason grade group (GGG) 1-3 PCa were included. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Annual trend analyses and multivariable logistic regression models focused on the rate of NOC PCa, the rate of primary pathologic Gleason ≥4 PCa, and the rate of either NOC PCa and/or primary pathologic Gleason ≥4 PCa. Adjustment was made for clinical tumor characteristics (prostatic specific antigen [PSA], clinical stage, and biopsy GGG). RESULTS AND LIMITATIONS: The rate of NOC PCa increased during the study period (18.7% vs 24.2%; p=0.002) and remained significant after adjustment (16.9% vs 22.3%; p=0.001) Similarly, the rate of pathologic primary Gleason ≥4 PCa increased during the study period (16.8% vs 23.0%, p=0.001) and remained significant after multivariable adjustment (10.8% vs 14.2%; p=0.002). Moreover, virtually the same findings were recorded when both endpoints were combined. Our results were confirmed in multivariable logistic regression analyses in which year of diagnosis was modeled as a continuous variable or a categorical variable or when a cubic spline approach was used. CONCLUSIONS: Rates of NOC PCa and primary Gleason ≥4 PCa increased over time among contemporary North American patients treated with RP. This finding may be related to better acceptance of active surveillance and watchful waiting by North American patients. PATIENT SUMMARY: In this report, we looked at pathologic outcomes for contemporary North American patients treated with radical prostatectomy. We found an increase in non-organ-confined and more aggressive prostate cancer.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Preisser F, Marchioni M, Nazzani S, et al. Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer. Eur Urol Oncol. 2018. PMID: 31100241. doi:10.1016/j.euo.2018.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。